LUCIUS Pharmaceutical announces the approval LuciNiro in Laos

Vientiane, Laos - October 6, 2025 -Lucius Pharmaceutical is focused on providing effective, safe, and reliable medications and services for patients all over the world., today announced LuciNiro (Nirogacestat) have been approved by the Ministry of Health of Laos.

Desmoid tumors, also known as aggressive fibromatosis, are non-malignant growths that can be found in the connective tissue and commonly occur in the arms, legs and abdomen. They are noncancerous because they don’t spread to other parts of the body. They are however, managed by oncologists as they have a tendency to be invasive aggressive and develop grow into other nearby organs. Slow growing tumors may not need treatment but fast growing would need treatment such as surgery, radiation therapy, chemotherapy or other medications.